CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Lukas Biomedical Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Lukas Biomedical Inc
No. 16, Zhongxiao Road, Banqiao District
Phone: +886 229500027p:+886 229500027 NEW TAIPEI, 220  Taiwan Ticker: 68146814
Business Summary
Lukas Biomedical Inc is a Taiwan-based company principally engaged in the sale of cosmetics, leasing and trading of medical equipment, as well as house leasing business and the provision of management consulting services. The Company is also engaged in the research, design, development and manufacture of immune cell products. The Company’s products are involved in beauty cosmetics, skin care products, daily necessities including dental floss, chewing gum, chewing spray, dry hair and other products. The Company also provides makeup series products including contains eye shadow gel, eye color palette, lip gloss, lipstick, lip wax. The medical equipment, care institutions and medical management’s products and services are engaged in the development of the experience charging model of entity operations with the service model of brand authorization, management consulting, property leasing and medical equipment leasing.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
5047 Medical, dental, and hospital equipment and supplies
5999 Miscellaneous retail stores, not elsewhere classified
6519 Lessors of real property, not elsewhere classified
8748 Business consulting services, not elsewhere classified
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board ZhichaoTang 8/12/2021 8/8/2017
General Manager, Director Chao'anLiu 8/12/2021 7/30/2021
Deputy General Manager, Director DailinLiu 10/3/2018 8/31/2018
6 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 41,874,371 (As of 7/26/2024)
Stock Exchange: TPO
Fax Number: +886 229500106


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024